Lind Asia

Lind Asia, a division of The Lind Partners, is an institutional fund manager that focuses on providing growth capital to small- and mid-cap companies, with a significant emphasis on the life sciences, biotechnology, and healthcare sectors. The firm specializes in direct investments across various structures, including equity, convertible debt, and hybrid instruments, to support clinical development and commercialization efforts. Since its inception, the group has completed numerous transactions globally, helping biotech companies bridge funding gaps during critical stages of their pipeline development. Lind Asia specifically targets opportunities within the Asia-Pacific region, leveraging its deep industry expertise to identify high-growth potential in emerging healthcare markets. The firm is known for its flexible investment approach and long-term commitment to its portfolio companies.